Ginkgo Bioworks Holdings, Inc. (DNA) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $170.16M | -25.1% |
| 2024 | $227.04M | -9.7% |
| 2023 | $251.46M | -47.4% |
| 2022 | $477.71M | +52.2% |
| 2021 | $313.84M | +309.4% |
| 2020 | $76.66M | +41.5% |
| 2019 | $54.18M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $170.16M | -25.1% |
| 2024 | $227.04M | -9.7% |
| 2023 | $251.46M | -47.4% |
| 2022 | $477.71M | +52.2% |
| 2021 | $313.84M | +309.4% |
| 2020 | $76.66M | +41.5% |
| 2019 | $54.18M | — |